Selected Grants
CN105 improves surrogate and functional outcomes after intracerebral hemorrhage (Subaward to AegisCN)
ResearchCo Investigator · Awarded by AegisCN LLC · 2024 - 2025Consultation for the Stanford Microbiome Therapies Initiative
ResearchPrincipal Investigator · Awarded by Stanford University · 2019 - 2024Bruce Burnett IPA
ResearchDirector · Awarded by National Institutes of Health · 2019 - 2020Biodosimetry High-Throughput Test RFP-16-100-SOL-00010
ResearchRegulatory Director · Awarded by DxTerity Diagnostics · 2017 - 2019Systemically administrered EGRFvIII-targeted bispecific antibody as an immunotherapeutic for glioblastoma.
FellowshipCollaborator · Awarded by National Institutes of Health · 2015 - 2019Duke CTSA (UL1)
ResearchCo Investigator · Awarded by National Institutes of Health · 2013 - 2018Immunology Quality Assesment Program Option 2
ResearchRegulatory Director · Awarded by National Institutes of Health · 2014 - 2017Regulatory Guidance for Academic Research of Drugs and Devices
ResearchProgram Director · Awarded by University of North Carolina - Chapel Hill · 2017 - 2017Point of Care Biodosimeter
ResearchRegulatory Director · Awarded by Department of Health and Human Services · 2009 - 2016Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2014 - 2015PTN Task Order #4: Hydroxyurea PK
ResearchCo Investigator · Awarded by National Institutes of Health · 2011 - 2014Clinical Trial Planning in Pompe Disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2013 - 2014Novel Ondansetron Formulation for Combination Treatment of Psychostimulant Abuse
Clinical TrialRegulatory Administrator · Awarded by National Institutes of Health · 2009 - 2013CTSA UL
ResearchRegulatory Director · Awarded by National Institutes of Health · 2006 - 2012External Relationships
- AegisCN LLC
- Immunity Bio (formerly Nantworks, formerly Etubics)
- LadeRx, LLC
- NIH
- Stanford University School of Medicine
- T3D Therapeutics Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.